Matrix Metalloproteinase Inhibitors Enhance the Efficacy of Frontline Drugs Against Mycobacterium Tuberculosis
PLoS Pathogens - United States
doi 10.1371/journal.ppat.1006974
Full Text
Open PDFAbstract
Available in full text
Date
April 26, 2018
Authors
Publisher
Public Library of Science (PLoS)